Imatinib Completed Phase 2 Trials for Recurrent Ovarian Epithelial Cancer / Primary Peritoneal Cavity Cancer / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Epithelial Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00036751Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer